CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry.
暂无分享,去创建一个
[1] L. Astrakas,et al. Shifting from region of interest (ROI) to voxel-based analysis in human brain mapping , 2010, Pediatric Radiology.
[2] L. Astrakas,et al. Voxel‐Based Morphometry and Voxel‐Based Relaxometry in Parkinsonian Variant of Multiple System Atrophy , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[3] Li Min Li,et al. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus , 2007, NeuroImage.
[4] M. Argyropoulou,et al. Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. , 2006, Arthritis and rheumatism.
[5] Wang Min,et al. Leuko araiosis , 2006 .
[6] Xiaohua Chen,et al. Gray matter reduction is correlated with white matter hyperintensity volume: A voxel-based morphometric study in a large epidemiological sample , 2006, NeuroImage.
[7] Fumiaki Tanaka,et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. , 2005, Brain : a journal of neurology.
[8] S. Pillemer,et al. Central nervous system disease in primary Sjögren’s syndrome: The role of magnetic resonance imaging , 2004 .
[9] P. Vermersch,et al. Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients , 2004, Medicine.
[10] H. C. Chui,et al. White matter lesions impair frontal lobe function regardless of their location , 2004, Neurology.
[11] H. Moutsopoulos,et al. Central nervous system involvement in Sjögren’s syndrome , 2004, Annals of the rheumatic diseases.
[12] Henry Brodaty,et al. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI , 2004, NeuroImage.
[13] L. Pierot,et al. Asymptomatic cerebral involvement in Sjögren's syndrome: MRI findings of 15 cases , 2004, Neuroradiology.
[14] M. Mataró,et al. Magnetic resonance abnormalities associated with cognitive dysfunction in primary Sjögren Syndrome , 2003, Journal of neurology.
[15] W. S. Huang,et al. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report , 2003, Rheumatology International.
[16] T. Kaji,et al. Primary Sjögren's syndrome initially manifested by optic neuritis: MRI findings , 2002, Neuroradiology.
[17] Karl J. Friston,et al. Why Voxel-Based Morphometry Should Be Used , 2001, NeuroImage.
[18] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[19] Sandra E. Black,et al. Callosal Atrophy Correlates with Temporal Lobe Volume and Mental Status in Alzheimer's Disease , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[20] Yukito Shinohara,et al. Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging , 2000, Journal of the Neurological Sciences.
[21] J. Dumas,et al. Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. , 1999, Annales de medecine interne.
[22] C. Anderson,et al. Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. , 1999, The Journal of rheumatology.
[23] L. Caniatti,et al. Neurological Involvement in Primary Sjo¨gren’s Syndrome: Clinical and Instrumental Evaluation in a Cohort of Italian Patients , 1999, Clinical Rheumatology.
[24] P. Chieng,et al. Regional cerebral blood flow and glucose metabolism in Sjögren's syndrome. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] B Horwitz,et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. , 1998, Archives of neurology.
[26] J. Garcìa,et al. Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.
[27] J. Haxby,et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.
[28] N. Patronas,et al. Anti‐Ro(SS‐A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS‐SS) , 1994, Neurology.
[29] Alexander El. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. , 1993 .
[30] Alexander El. Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. , 1992 .
[31] R. Molina,et al. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome. , 1992, The American journal of medicine.
[32] R D Tien,et al. Crossed cerebellar diaschisis and crossed cerebellar atrophy: correlation of MR findings, clinical symptoms, and supratentorial diseases in 26 patients. , 1992, AJR. American journal of roentgenology.
[33] A. Delacourte,et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? , 1991, Journal of neurology, neurosurgery, and psychiatry.
[34] A. Drosos,et al. Neuropsychiatric abnormalities in primary Sjögren's syndrome. , 1989, Clinical and experimental rheumatology.
[35] O. Selnes,et al. Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. , 1988, Annals of internal medicine.
[36] R. Bone,et al. Primary Sjogren syndrome: clinical and immunopathologic features. , 1984, Seminars in arthritis and rheumatism.
[37] E. Alexander,et al. Neurologic Complications of Primary Sjögren's Syndrome , 1982, Medicine.